Vectors Research Management, LLC / LLY
Vectors Research Management, LLC’s Eli Lilly & Co Position
Does Vectors Research Management, LLC own Eli Lilly & Co (LLY)? Yes — 4.3K shares worth $4M (+1.15% of its 13F portfolio) as of Q1 2026, up from 4.3K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
4.3K
% of Portfolio
+1.15%
Quarters Held
28
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 4.3K | $4M | +1.15% |
| Q4 2025 | 4.3K | $5M | +1.40% |
| Q3 2025 | 4.3K | $3M | +1.02% |
| Q2 2025 | 4.3K | $3M | +1.14% |
| Q1 2025 | 4.3K | $4M | +1.23% |
| Q4 2024 | 4.3K | $3M | +1.14% |
| Q3 2024 | 4.3K | $3,837 | +1.16% |
| Q2 2024 | 4.3K | $3,915 | +1.20% |
| Q1 2024 | 4.3K | $3,371 | +0.95% |
| Q4 2023 | 139.9K | $2,469 | +0.70% |
| Q3 2023 | 4.4K | $2,371 | +0.77% |
| Q2 2023 | 4.4K | $2,082 | +0.59% |
| Q1 2023 | 4.5K | $1,534 | +0.40% |
| Q4 2022 | 4.7K | $1,707 | +0.44% |
| Q3 2022 | 4.7K | $2M | +0.43% |
| Q2 2022 | 4.7K | $2M | +0.38% |
| Q1 2022 | 4.7K | $1M | +0.29% |
| Q4 2021 | 4.7K | $1M | +0.27% |
| Q3 2021 | 4.6K | $1M | +0.25% |
| Q2 2021 | 4.6K | $1M | +0.27% |
| Q1 2021 | 4.6K | $865,000 | +0.24% |
| Q4 2020 | 4.6K | $782,000 | +0.24% |
| Q3 2020 | 4.1K | $604,000 | +0.22% |
| Q2 2020 | 4.0K | $653,000 | +0.26% |
| Q1 2020 | 4.0K | $552,000 | +0.26% |
| Q4 2019 | 4.0K | $523,000 | +0.21% |
| Q3 2019 | 4.0K | $445,000 | +0.22% |
| Q2 2019 | 4.0K | $441,000 | +0.24% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vectors Research Management, LLC’s full portfolio or all institutional holders of LLY.